Gut microbiota has been recently established to have a contributory role in the development of cardiometabolic disorders, such as atherosclerosis, obesity, and type 2 diabetes. Growing interest has focused on the modulation of gut microbiota as a therapeutic strategy in cardiovascular diseases and metabolic disorders. In this paper, we have reviewed the impact of gut microbiota on metabolic disorders and cardiovascular disease risk, focusing on the newest findings in this field.
|Numero di pagine||8|
|Rivista||Current Cardiology Reports|
|Stato di pubblicazione||Pubblicato - 2015|
- Cardiovascular disease
- Gut microbiota
- Type 2 diabetes